Clinical Neurological Society of America (CNSA) 48th Annual Meeting

Clinical Neurological Society of America (CNSA) 48th Annual Meeting is organized by Clinical Neurological Society of America (CNSA) and will be held from Jan 15 - 18, 2022 at Wyndham Grand Clearwater Beach, Clearwater Beach, Florida, United States of America.

Target Audience :
The 48th Annual Meeting of the Clinical Neurological Society of America is designed to provide practicing neurologists with the most up-to-date information for the diagnosis and management of the patient with neurologic conditions. Each section is built around a specific clinical topic or topics presented by experts who provide practical information for evaluation and treatment of patients with neurological conditions.

The Annual Meeting is designed primarily for practicing neurologists. Other health care providers including fellows, residents, physician assistants, nurse practitioners, neurosurgeons, psychiatrists, social workers, doctors of pharmacy and neuropsychologists who work in patient care may benefit.

Statement of Educational Need:
To be more capable of practice at the level of the standard of care, neurologists need a better understanding of the pathophysiology of movement disorders, cognitive conditions, multiple sclerosis, pediatric neurological conditions, neuromuscular conditions, stroke, epilepsy, headache and COVID-19. They also need improved diagnostic evaluation and management strategies in addition to novel approaches, including the use of artificial intelligence, in monitoring patients with these conditions. This conference is designed to improve understanding of and use of current clinical practice guidelines and recent research findings in the participant’s practices.

Educational Objectives :
After completing this CME activity, learners should be able to:
• Describe how to manage off periods in Parkinson’s disease based on current clinical practice guidelines.
• Explain how to evaluate cognitive disorders based on current clinical practice guidelines.
• Define the different medications used to treat demyelinating disorders and decision pathways for using common treatments.
• Identify treatment and management approaches for pediatric patients who have stroke or Tourette syndrome.
• Discuss approaches for using telestroke to improve patient outcomes. ·
• Explain strategies for clinical encounters with patients who have ischemic stroke using artificial intelligence technologies.
• Outline how to use wearables for epilepsy monitoring based on current clinical practice guidelines.
• Describe how COVID-19 affects the management of Huntington’s disease.
• Explain how to treat CSF pressure disorders according to current clinical practice guidelines.
• Describe new medications for treating migraine according to current clinical practice guidelines.
• Discuss established and novel therapies for Lambert-Eaton syndrome and myasthenia gravis.
• Explain management approaches for diabetic neuropathy variants.